BATS BZX Real-Time Price
As of 1:55pm ET
| -1.61 / -1.71%|
The 20 analysts offering 12-month price forecasts for AbbVie Inc have a median target of 125.00, with a high estimate of 157.00 and a low estimate of 80.00. The median estimate represents a +34.83% increase from the last price of 92.71.
The current consensus among 23 polled investment analysts is to Hold stock in AbbVie Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.